Jeantet advises Sartorius on acquisition of Polyplus for approximately 2.4 B euros
Paris, April 3, 2023, Jeantet has advised the life science group Sartorius AG (“Sartorius”), on its signing on 31 March 2023 of an agreement to acquire France-based Polyplus for approximately 2.4 billion euros from private investors including ARCHIMED and WP GG Holdings IV B.V., an affiliate of Warburg Pincus.
Polyplus, with around 270 employees, develops and produces transfection as well as other DNA/RNA delivery reagents and plasmid DNA in high quality and at GMP grade. These are key components in the production of viral vectors used in cell and gene therapies and other advanced medicinal therapeutic products. Recording significant growth rates, Polyplus is expected to generate sales revenue in the upper double-digit million-euro range and a very substantial EBITDA margin in 2023.
The proposed transaction is subject to customary conditions, including completion of the information and consultation of the works’ council and approval by regulatory authorities and is expected to close during the third quarter of 2023.
Founded in 2001, Polyplus is based in Strasbourg, France, and has locations in France, Belgium, the U.S., and China.
The Sartorius Group is a leading international partner of life sciences research and the biopharmaceutical industry. The company, based in Goettingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. In fiscal year 2022, the company generated sales revenue of approximately 4.2 billion euros. At the end of 2022, around 16,000 employees were working for customers across the globe.
Share
Jeantet advises T.Capital on the EUR 58 millions series C fundraising of Filigran
Paris, 8 october 2025 – Filigran is an innovative French start-up operating in the development and marketing of cybersecurity solutions based on open source software, enabling businesses to optimize the management of their cybersecurity systems in order to anticipate any threats and detect any incidents. The investment will enable Filigran to accelerate its expansion in […]
| CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises LBO France on the sale of its stake in Serapid to Capital Croissance and its co-investors
Paris, September 30, 2025 – Jeantet advised LBO France on the sale of its stake in Serapid, an expert in rigid chain technology for moving heavy loads, to Capital Croissance and its co-investors. Capital Croissance, the entrepreneurs’ club dedicated to growing SMEs and mid-cap companies, has acquired a majority stake in Serapid alongside the company’s […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | TAX
Jeantet advices New Deal Advisors in its integration into the Eight Advisory Group
Paris, October 6, 2025 – Jeantet advised New Deal Advisors, an Italian financial and transactional advisory firm, with its integration into the international Eight Advisory group, a leading provider of financial, operational, and strategic advisory services. New Deal Advisors has around 50 employees and mainly advises mid- and large-cap private equity funds. This merger marks […]
| CORPORATE – M&A – PRIVATE EQUITY
JEANTET ADVISES HOFFMANN GREEN CEMENT TECHNOLOGIES ON ITS SHARE CAPITAL INCREASE WITH PREFERENTIAL SUBSCRIPTION RIGHTS AND RESERVED ISSUANCE OF BONDS CONVERTIBLE INTO SHARES
Paris, 3 October 2025 – Jeantet has advised Hoffmann Green Cement Technologies, a company listed on Euronext Growth Paris, on its share capital increase with preferential subscription rights and the reserved issuance of convertible bonds (“CBs”) to Inveready, for a total amount of €13.9 million. The subscription period was open from 11 September to 23 […]
| CORPORATE – M&A – PRIVATE EQUITY
Jeantet advised Coincheck Group N.V. on the signature of an agreement to acquire APLO SAS
Paris, September 12, 2025 – Jeantet advised Coincheck Group N.V., holding company of Coincheck, Inc., one of Japan’s leading crypto asset exchanges, on the signature of an agreement to acquire Aplo SAS, a French digital asset prime brokerage for institutional crypto investors. Coincheck Group N.V. was advised by a joint team of Jeantet and the […]
Paris | CORPORATE – M&A – PRIVATE EQUITY | BANKING AND FINANCIAL REGULATION | INTELLECTUAL PROPERTY | TECH & DATA | EMPLOYMENT | TAX LAW
Jeantet advises DERICHEBOURG AERONAUTICS on its acquisition of control of the SACI TECHNOLOGY GROUP
Paris, 10 September 2025 – Jeantet advised Derichebourg Aeronautics on its acquisition of control of the companies of the SACI Technology Group from its reference shareholder, Be Box Development. The SACI Technology Group companies are active in engineering and design services for the industrialization of products in the aeronautics industry. Through this acquisition, under which […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises LIDL on the acquisition of 19 supermarkets under the AUCHAN brand
Paris, July 25, 2025 – Jeantet advised the retail chain Lidl on the planned acquisition of 19 supermarkets currently operated under the Auchan banner. Auchan’s employee representative bodies are currently being consulted regarding the contemplated transaction. The completion of the deal remains subject to the fulfilment of several conditions, including clearance from the French Competition […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises a consortium of banks on the financing of the acquisition and refurbishment of hotel Paris-Charles de Gaulle by LUITEN VAN DER VALK GROUP
Paris, July 23, 2025 – Jeantet has advised ING BANK N.V., COÖPERATIEVE RABOBANK U.A. and ABN AMRO BANK N.V., in connection with a structured secured financing to LUITEN VAN DER VALK hotel and leisure group for the acquisition of the SHIR, a company owning the Atrium Hotel & Conference Centre Paris – Charles de Gaulle, […]
Paris | BANK-FINANCE-REGULATORY
Jeantet advises DREAMPATH DIAGNOSTICS on the acquisition of a stake by SUMMIT PARTNERS
Paris, July 16, 2025 – Jeantet advised Dreampath Diagnostics, a group specializing in automation and traceability of anatomical pathology samples, on Summit Partners’ acquisition of a minority stake. The transaction aims to accelerate Dreampath Diagnostics’ international growth and strengthen its offering of solutions for digitizing laboratory processes. Founded in 2012, the Dreampath Diagnostics group offers […]
Paris | TAX LAW | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises COGELEC and the shareholders of COGELEC DEVELOPPEMENT, majority shareholder of COGELEC, in the context of the proposed acquisition of COGELEC DEVELOPPEMENT by LEGRAND, prior to the filing of a simplified tender offer on COGELEC shares
Paris, July 11, 2025 – Jeantet advises Cogelec (a company listed on the Euronext Growth Paris market), French specialist of the housing access control, as well as the shareholders of Cogelec Développement, indirect majority shareholder of Cogelec, in the context of the contemplated acquisition of the Cogelec Développement shares by Legrand (a company listed on […]
Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW
Jeantet advises Oxylabs in connection with its acquisition of Scrapingbee
Paris, July 4, 2025 – Jeantet advised Oxylabs, one of the market-leading companies in web scraping solutions, in connection with its acquisition of ScrapingBee, a French fast-growing web scraping company known for its developer-friendly solutions. Through this strategic acquisition, Oxylabs significantly expands the Oxylabs group’s ecosystem as well as its target clientele, now addressing direct […]
Paris | CORPORATE – M&A – PRIVATE EQUITY
Jeantet advises BPIFRANCE on the financing of the development and construction of a wind fram owned by the WYSERNERGY group
Paris, June 24, 2025 – Jeantet advised BPIFRANCE on the implementation of financing in the principal amount of approximately €17 million to fund the development and construction of a wind farm located in the municipality of Faux-Fresnay, led by the WYSENERGY group.
Paris | BANK-FINANCE-REGULATORY